Nippon Gases Deploys Juniper Networks’ AI-Native Networking Platform to Foster Growth and Accelerate Innovation
New wired and wireless network consolidates and transforms operations to underpin mission-critical gas production across Europe
Juniper Networks®, (NYSE: JNPR), a leader in secure, AI-Native Networking, today announced that Nippon Gases, one of the largest industrial gas companies in Europe, has implemented Juniper’s AI-Native wired and wireless LAN solutions to enhance mobile experiences across Nippon Gases’s IT and operational technology (OT) environments whilst streamlining network operations to foster digital innovation. As a key element of Juniper’s AI-Native Networking Platform, the new infrastructure uses Mist AI and cloud native capabilities to provide industry-leading efficiency, resiliency and visibility to Nippon Gases, resulting in exceptional user and operator experiences across offices, specialty labs, manufacturing plants, trucks, pipelines and ships.
With operations in 13 countries, Nippon Gases produces essential gases such as oxygen, nitrogen, hydrogen and carbon dioxide, serving multiple industries including healthcare, food and beverage, manufacturing and biotech.
By standardizing on Juniper’s unique AI for networking capabilities, Nippon Gases accelerates service deployment, simplifies operations, reduces total cost of ownership (TCO) and operational expenses, delivering exceptional end-to-end user and IT experiences. Additionally, Juniper’s AI-Native Networking Platform will help Nippon Gases accelerate new site set ups, increase trouble-ticket resolution with automation, optimize component inventory management and enable efficient, consistent network operations. The IT team can now automate the base configurations for each site and deploy the network rapidly with Zero Touch Provisioning. Role-based access delegates tasks to local teams while maintaining central control, simplifying maintenance through a standardized network. The IT team can put users’ digital experiences first and reduce the IT workload across the entire network life cycle.
News Highlights:
- Juniper Mist Wireless (Wi-Fi) Assurance provides the fastest way to deploy and the easiest way to manage personalized Wi-Fi experiences, including up to 90 percent elimination in wireless trouble tickets, up to 85 percent fewer truck rolls and up to 9x faster deployment times in some instances. With Juniper, Nippon Gases’ Wi-Fi is fast, secure and reliable, even in the busiest, most experience-critical areas. For instance: reliable Wi-Fi supports seamless communication between industrial IoT devices, sensors and control systems, ensuring uninterrupted operations and real-time monitoring and enables technicians to access and update digital workflows or maintenance logs instantly.
- Juniper Mist Wired Assurance delivers reliable, secure connectivity experiences for stationary devices and IoT endpoints through AI-driven network operations.
- Juniper Networks® EX Series Switches enable unified visibility and control over both wireless and wired networking through a common Mist AI engine and microservices cloud infrastructure.
- Juniper’s Marvis™ Virtual Network Assistant is used across Nippon Gases’ wired and wireless domains to simplify and automate network operations. Acting as an extended member of the IT team, Marvis provides proactive actions and Self-Driving Network™ operations. It continuously optimizes the user experience and provides visibility into impending problems. As a result, IT operations have clear and secure visibility into user and application experiences. AIOps boosts network reliability with automated actions, optimizing the network in real time and enabling rapid troubleshooting when needed.
- A Juniper Enterprise Agreement (EA) gives Nippon Gases an easier way to purchase, consume and manage the portfolio of Juniper AI-Native Networking Platform software and support services anywhere in its business.
Supporting Quotes:
“Our business is incredibly dynamic and highly competitive. We are frequently building new factories, expanding our footprint and driving growth through acquisitions. These fast-paced changes mean IT typically has little lead time to support the new business demands that keep us ahead of the market. With Juniper’s AI-Native Networking Platform, we can rapidly yet easily deploy networks at new sites, ensuring seamless, secure connectivity and operational readiness. Juniper’s innovative solutions allow us to scale efficiently and consistently, meet business needs on tight timelines, and maintain the high standards our customers expect of a market leader.”
- Bjorn Dupont, IT Network Manager, Nippon Gases
“Nippon Gases needed to harmonize its complex network infrastructure to improve stability and support quality control. Centralized management was a particular challenge, as IT teams had to manage network devices individually across multiple countries. Simplifying network provisioning and operations therefore became a top priority. This requirement plays to our AI-Native Networking Platform’s strengths—offering insight-driven and automated solutions to mitigate manual, decentralized management. With Juniper, Nippon Gases can quickly identify, monitor and correlate network events in real time, proactively addressing potential issues before they impact operations and experiences.”
- Gos Hein van de Wouw, Vice President, Enterprise Sales, EMEA, Juniper Networks
About Juniper Networks
Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up to leverage AI to deliver the best and most secure user experiences from the edge to the data center and cloud. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter), LinkedIn, and Facebook.
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241212532821/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom